Future perspectives in the treatment of femoro-popliteal arterial occlusions

被引:0
作者
Gisbertz, SS
Hissink, RJ
De Vries, JPPM
Moll, FL
机构
[1] Univ Utrecht, Med Ctr, Dept Vasc Surg, NL-3508 GA Utrecht, Netherlands
[2] St Antonius Hosp, Dept Vasc Surg, Nieuwegein, Netherlands
关键词
superficial femoral artery; popliteal artery; atherosclerosis; arterial occlusive disease; endovascular surgical procedures;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Femoro-popliteal occlusive disease represents the most frequent localization of atherosclerosis in the lower extremities. Treatment of this disease has changed remarkably in the last decade. A definite treatment strategy has still to be established. The pathophysiology is described. A general overview of the state-of-the art treatment modalities and the most recent developments is given. This is divided into non-interventional preventive and supportive therapy, endovascular interventional therapy, and surgical interventional therapy. The development of medical therapy has expanded enormously and is progressing still. in the wide range of interventional treatment modalities, there has been a change from invasive bypass surgery to more refined techniques like endarterectomy and percutaneous endovascular therapy. This trend towards restoring the patency of the artery using the vessel wall itself as a conduit, leads to a term encompassing all these treatment modalities, known as restorative intervention. Peri-procedural risks of restorative interventions are of a much lesser degree compared to bypass surgery. Reports of patency rates show a steady increase. It is expected that patency rates will eventually equal or even surpass those of bypass surgery. in conclusion, a treatment strategy for femoro-popliteal occlusions in the future is proposed as follows: the first line of interventional therapy in femoro-pophteal occlusions should be a restorative intervention. With adequate adjuvant medical therapy and sufficient monitoring, this will be the definite treatment for the majority of patients. Bypass surgery should be regarded as the second line of interventional. therapy and should be reserved for those patients in whom restorative interventions fail.
引用
收藏
页码:371 / 384
页数:14
相关论文
共 144 条
  • [1] Femoropopliteal arteries: Immediate and long-term results with a Dacron-covered stent-graft
    Ahmadi, R
    Schillinger, M
    Maca, T
    Minar, E
    [J]. RADIOLOGY, 2002, 223 (02) : 345 - 350
  • [2] Ameli F M, 1989, Ann Vasc Surg, V3, P20, DOI 10.1016/S0890-5096(06)62380-7
  • [3] [Anonymous], COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000017
  • [4] Ansel GM, 2000, J INVASIVE CARDIOL, V12, P382
  • [5] The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
    Armitage, Jane
    Collins, Rory
    Bowman, Louise
    Parish, Sarah
    Sleight, Peter
    Peto, Richard
    Meade, T.
    Youngman, L.
    Buxton, M.
    de Bono, D.
    George, C.
    Fuller, J.
    Keech, A.
    Mansfield, A.
    Pentecost, B.
    Simpson, D.
    Warlow, C.
    McNamara, J.
    O'Toole, L.
    Doll, R.
    Wilhelmsen, L.
    Fox, K. M.
    Hill, C.
    Sandercock, P.
    [J]. BMC MEDICINE, 2005, 3 (1)
  • [6] Bagger JP, 1997, CIRCULATION, V95, P411
  • [7] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [8] BALSANO F, 1989, J LAB CLIN MED, V114, P84
  • [9] EXPERIENCE WITH INSITU SAPHENOUS-VEIN BYPASSES DURING 1981 TO 1989 - DETERMINANT FACTORS OF LONG-TERM PATENCY
    BERGAMINI, TM
    TOWNE, JB
    BANDYK, DF
    SEABROOK, GR
    SCHMITT, DD
    [J]. JOURNAL OF VASCULAR SURGERY, 1991, 13 (01) : 137 - 149
  • [10] BERGAN JJ, 1982, SURGERY, V92, P921